基本信息
文件名称:VUF11207-TFA-生命科学试剂-MCE.pdf
文件大小:467.43 KB
总页数:1 页
更新时间:2025-05-20
总字数:约2.16千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

VUF11207TFA

Cat.No.:HY-115615

CASNo.:1492153-74-8

分?式:C??H??F?N?O?

分?量:584.6

作?靶点:CXCR

作?通路:GPCR/GProtein;Immunology/Inflammation

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性VUF11207TFA(Compound29)是?种CXCR7激动剂(pKi为8.1),可诱导CXCR7的β-arrestin2募集(

pEC50为8.8)和随后的内在化(pEC50为7.9)。

IC50TargetCXCR7

8.1(pKi)

客户使?本产品发表的科研?献

?CellDeathDis.2024Jun19;15(6):434.

?CellMolLifeSci.2024Mar13;81(1):132.

Seemorecustomervalidationsonwww.MedChemE

REFERENCES

[1].WijtmansM,etal.Synthesis,modelingandfunctionalactivityofsubstitutedstyrene-amidesassmall-moleculeCXCR7agonists.EurJ

MedChem.2012May;51:184-92.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021Fax:021